ArticleMolecular and clinical oncology2022

Combination of palbociclib with adjuvant endocrine therapy for treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer: An experience at two cancer centers in Saudi Arabia.

Meteb H Al-Foheidi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.